Market Overview:
The global radiopharmaceutical synthesizers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. Based on type, the global radiopharmaceutical synthesizers market is segmented into nuclear reactor-based and cyclotron-based synthesizers. The nuclear reactor-based segment is expected to account for the largest share of the global radiopharmaceutical synthesizers market in 2018. This segment is projected to grow at a CAGR of 5.7% during the forecast period from 2018 to 2030 due to increase in demand for radioisotopes worldwide. However, the cyclotron-based segment is projected to grow at a higher CAGR than that of nuclear reactor-based segments during the forecast period from 2018to 2030 owing high adoption rates across developed countries such as UAS, Japan, Canada etc.
Product Definition:
A radiopharmaceutical synthesizer is a device used to produce radioactive pharmaceuticals. These synthesizers are important because they allow for the production of high-quality, pure pharmaceuticals that can be used in medical procedures.
Cyclotron:
A cyclotron is a particle accelerator, which is used for accelerating the particles to high speed and then making them collision with other particles in a predefined manner. The collisions cause radioactive transformations.
The most commonly used isotopes for medical applications are radionuclides that are produced by neutron capture or electron-impact ionization. Neutron capture process produces Iodine (I), while electron-impact ionization produces Xenon (Xe).
Nuclear Reactor:
It utilizes a self-sustained nuclear chain reaction to produce radioisotopes which can be further utilized in diagnostic and therapeutic applications.
Application Insights:
The academic and research centers segment held the largest market share of over 30% in 2017. Academic and research centers are majorly involved in developing new products or improving existing products for clinical use. This leads to an increase in product demand from these institutions.
Radiation therapy is one of the most effective treatments available against various cancers including lung, breast, prostate as well as other malignant tumors that have not responded to chemotherapy or surgery yet.
Regional Analysis:
North America dominated the global radiopharmaceutical synthesizers market in 2017. This can be attributed to factors such as favorable reimbursement policies, high healthcare expenditure, and increasing R&D activities in this region. For instance, in December 2016; Omnitrope Authorization Request (ORAL) was approved by FDA which allows its use for diagnostic imaging procedures that require rapid blood clotting time such as CT scans or X-ray films.
Asia Pacific is anticipated to grow at a lucrative rate over the forecast period owing to rising healthcare expenditure.
Growth Factors:
- Increasing demand for radiopharmaceuticals for diagnosis and treatment of various diseases
- Growing number of cancer patients worldwide
- Rising awareness about the benefits of radiopharmaceuticals
- Technological advancements in radiopharmaceutical synthesizers market
- Increasing investments by pharmaceutical companies in research and development of new radiopharmaceutical products
Scope Of The Report
Report Attributes
Report Details
Report Title
Radiopharmaceutical Synthesizers Market Research Report
By Type
Cyclotron, Nuclear Reactor, Radionuclide Generator
By Application
Hospitals, Pharmaceutical Companies, Academic and Research Centers, Others
By Companies
IBA RadioPharma Solutions, Mercurius Health, Elysia, Advion, Inc, Advanced Cyclotron Systems, Rosatom(JSC Isotope), Lantheus Medical Imaging, Inc, BV Cyclotron VU, NorthStar Medical Technologies, LabLogic Systems Ltd, IBA RadioPharma Solutions
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
167
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Radiopharmaceutical Synthesizers Market Report Segments:
The global Radiopharmaceutical Synthesizers market is segmented on the basis of:
Types
Cyclotron, Nuclear Reactor, Radionuclide Generator
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pharmaceutical Companies, Academic and Research Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- IBA RadioPharma Solutions
- Mercurius Health
- Elysia
- Advion, Inc
- Advanced Cyclotron Systems
- Rosatom(JSC Isotope)
- Lantheus Medical Imaging, Inc
- BV Cyclotron VU
- NorthStar Medical Technologies
- LabLogic Systems Ltd
- IBA RadioPharma Solutions
Highlights of The Radiopharmaceutical Synthesizers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cyclotron
- Nuclear Reactor
- Radionuclide Generator
- By Application:
- Hospitals
- Pharmaceutical Companies
- Academic and Research Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radiopharmaceutical Synthesizers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A radiopharmaceutical synthesizers is a machine that can create pharmaceuticals from radioactive materials.
Some of the major players in the radiopharmaceutical synthesizers market are IBA RadioPharma Solutions, Mercurius Health, Elysia, Advion, Inc, Advanced Cyclotron Systems, Rosatom(JSC Isotope), Lantheus Medical Imaging, Inc, BV Cyclotron VU, NorthStar Medical Technologies, LabLogic Systems Ltd, IBA RadioPharma Solutions.
The radiopharmaceutical synthesizers market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radiopharmaceutical Synthesizers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radiopharmaceutical Synthesizers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radiopharmaceutical Synthesizers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radiopharmaceutical Synthesizers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radiopharmaceutical Synthesizers Market Size & Forecast, 2018-2028
4.5.1 Radiopharmaceutical Synthesizers Market Size and Y-o-Y Growth
4.5.2 Radiopharmaceutical Synthesizers Market Absolute $ Opportunity
Chapter 5 Global Radiopharmaceutical Synthesizers Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Radiopharmaceutical Synthesizers Market Size Forecast by Type
5.2.1 Cyclotron
5.2.2 Nuclear Reactor
5.2.3 Radionuclide Generator
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Radiopharmaceutical Synthesizers Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Radiopharmaceutical Synthesizers Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pharmaceutical Companies
6.2.3 Academic and Research Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radiopharmaceutical Synthesizers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radiopharmaceutical Synthesizers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Radiopharmaceutical Synthesizers Analysis and Forecast
9.1 Introduction
9.2 North America Radiopharmaceutical Synthesizers Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Radiopharmaceutical Synthesizers Market Size Forecast by Type
9.6.1 Cyclotron
9.6.2 Nuclear Reactor
9.6.3 Radionuclide Generator
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Radiopharmaceutical Synthesizers Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pharmaceutical Companies
9.10.3 Academic and Research Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Radiopharmaceutical Synthesizers Analysis and Forecast
10.1 Introduction
10.2 Europe Radiopharmaceutical Synthesizers Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Radiopharmaceutical Synthesizers Market Size Forecast by Type
10.6.1 Cyclotron
10.6.2 Nuclear Reactor
10.6.3 Radionuclide Generator
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Radiopharmaceutical Synthesizers Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pharmaceutical Companies
10.10.3 Academic and Research Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Radiopharmaceutical Synthesizers Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Radiopharmaceutical Synthesizers Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Radiopharmaceutical Synthesizers Market Size Forecast by Type
11.6.1 Cyclotron
11.6.2 Nuclear Reactor
11.6.3 Radionuclide Generator
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Radiopharmaceutical Synthesizers Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pharmaceutical Companies
11.10.3 Academic and Research Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Radiopharmaceutical Synthesizers Analysis and Forecast
12.1 Introduction
12.2 Latin America Radiopharmaceutical Synthesizers Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Radiopharmaceutical Synthesizers Market Size Forecast by Type
12.6.1 Cyclotron
12.6.2 Nuclear Reactor
12.6.3 Radionuclide Generator
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Radiopharmaceutical Synthesizers Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pharmaceutical Companies
12.10.3 Academic and Research Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Radiopharmaceutical Synthesizers Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Radiopharmaceutical Synthesizers Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Radiopharmaceutical Synthesizers Market Size Forecast by Type
13.6.1 Cyclotron
13.6.2 Nuclear Reactor
13.6.3 Radionuclide Generator
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Radiopharmaceutical Synthesizers Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pharmaceutical Companies
13.10.3 Academic and Research Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radiopharmaceutical Synthesizers Market: Competitive Dashboard
14.2 Global Radiopharmaceutical Synthesizers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 IBA RadioPharma Solutions
14.3.2 Mercurius Health
14.3.3 Elysia
14.3.4 Advion, Inc
14.3.5 Advanced Cyclotron Systems
14.3.6 Rosatom(JSC Isotope)
14.3.7 Lantheus Medical Imaging, Inc
14.3.8 BV Cyclotron VU
14.3.9 NorthStar Medical Technologies
14.3.10 LabLogic Systems Ltd
14.3.11 IBA RadioPharma Solutions
